Orthofix Medical (OFIX) Depreciation & Amortization (IS) (2018 - 2026)

Orthofix Medical (OFIX) has 8 years of Depreciation & Amortization (IS) data on file, last reported at $13.5 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (IS) fell 60.81% year-over-year to $13.5 million; the trailing twelve-month figure through Mar 2026 stood at $77.7 million (up 9.4% YoY), and the FY2023 full-year result was $53.1 million, up 82.86% from the prior year.
• Depreciation & Amortization (IS) for Q1 2026 stood at $13.5 million, up from $12.9 million in the prior quarter.
• Across five years, Depreciation & Amortization (IS) topped out at $34.4 million in Q1 2025 and bottomed at $6.5 million in Q2 2022.
• A 4-year average of $13.6 million and a median of $13.2 million in 2025 frame the typical range for Depreciation & Amortization (IS).
• Across the five-year window, Depreciation & Amortization (IS) slumped 61.35% in 2022 and gained 20.23% in 2025, its largest moves.
• Tracing OFIX's Depreciation & Amortization (IS) over 4 years: stood at $7.4 million in 2022, then surged by 104.46% to $15.2 million in 2024, then slipped by 14.71% to $12.9 million in 2025, then rose by 4.27% to $13.5 million in 2026.
• According to Business Quant data, Depreciation & Amortization (IS) over the past three periods registered $13.5 million, $12.9 million, and $16.9 million for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison